FDA boasts better approval rates than Europe
November 4, 2011Medical Communications, Research and Development FDA, approvals
US regulator the FDA has approved more drugs and at a faster rate than its European counterpart.A new report by …
GSK, Pfizer joint venture to start manufacturing ops in Russia
November 4, 2011Manufacturing and Production GSK, Pfizer, manufacturing
A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …
Ketchum wins International Consultancy of the Year award
November 3, 2011Medical Communications Ketchum, Ketchum Pleon, PR
Ketchum Pleon has accepted the International Consultancy of the Year award on behalf of the global firm Ketchum at the …
GSK pays $3 billion to settle US marketing probe
November 3, 2011Sales and Marketing GSK, compliance, federal investigation
GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …
Synergy Vision hires Caroline Loder and Natalie Ferguson
November 3, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Synergy Vision
Synergy Vision, the London-based medical communications agency, has hired Caroline Loder as a senior medical writer and Natalie Ferguson as a …
Teva sees modest growth as US sales fall
November 3, 2011Business Services, Sales and Marketing Teva, generics
Sales growth at Teva was modest in Q3, rising 2% to $4.34 billion, with growth predominately coming from branded drugs.This …
Doctors decry cost-cutting in HIV treatment
November 2, 2011Sales and Marketing HIV, NHS, Reyataz
Doctors in London are opposing a decision to switch HIV patients to a cheaper drug, saying it could harm patients. …
Richard Daniell appointed as managing director of Teva UK
November 2, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Teva Pharmaceutical
Richard Daniell has been appointed as managing director for Teva UK, and will be responsible for all Teva’s commercial activities …
Sanofi to become world’s biggest drug maker
November 2, 2011Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10
Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts. Pfizer’s nine-year …
Prevnar and Lyrica lift Pfizer results
November 1, 2011Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry
Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter. …
Lundbeck appoints two new R&D vice presidents
November 1, 2011Research and Development Lundbeck, R&D
Lundbeck has appointed Jens Peter Balling and Iman Barilero as vice presidents of its research and development organisation. The new …
Obama takes action to curb medicine shortages
November 1, 2011Manufacturing and Production, Research and Development, Sales and Marketing FDA, Obama, drugs
US President Barack Obama has ordered the FDA and Department of Justice to take action to reduce and prevent medicine …
Lonza sees continued recovery in third quarter
November 1, 2011Manufacturing and Production, Sales and Marketing Lonza, Q3, manufacturing and production
Revenue growth at contract manufacturing organisation Lonza in the third quarter was once again undermined by the strength of the …
NICE U-turn on Boehringer’s Pradaxa
November 1, 2011Sales and Marketing NICE, Pradaxa
NICE is now recommending Boehringer Ingelheim’s Pradaxa for stroke prevention after initially rejecting the drug on cost-effectiveness issues. NICE has …
Shadow Commissioning Board goes live
October 31, 2011Medical Communications Commissioning Board, DH, NHS
The NHS Commissioning Board, the new central and powerful committee that will co-ordinate the health service in England, has been …
UK researchers claim advance in chiral manufacturing
October 31, 2011Manufacturing and Production Cambridge University, chiral manufacturig, chiral manufacturing
Researchers from the UK says a new technique which uses metal surfaces as templates to make drug compounds with specific …
Working Life: Adaptimmune’s Helen Tayton-Martin
October 31, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, Working Life
Helen Tayton-Martin who is an executive director at Adaptimmune, talks to Pharmafocus about her role and working in cell therapy. …
Contract research news in brief
October 31, 2011Manufacturing and Production, Research and Development CRO, manufacturing and production
PPD looks set to go private, WuXi and Quintiles stride down the acquisition trail plus updates from TrialReach and Aragen …
FDA’s rejection of Avastin creates conflict
October 31, 2011Research and Development, Sales and Marketing FDA, avastin, breast cancer
Oncology experts have expressed concern at the FDA’s rejection of Roche’s Avastin for the treatment of advanced breast cancer. A …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
